Publication:
Toward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor

dc.contributor.authorErol, Ismail
dc.contributor.authorÇoşut, Bünyemin
dc.contributor.authorDurdagi, Serdar
dc.contributor.institutionErol, Ismail, Department of Chemistry, Gebze Teknik Üniversitesi, Gebze, Turkey, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.contributor.institutionÇoşut, Bünyemin, Department of Chemistry, Gebze Teknik Üniversitesi, Gebze, Turkey
dc.contributor.institutionDurdagi, Serdar, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey, Neuroscience Program, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.date.accessioned2025-10-05T16:03:16Z
dc.date.issued2019
dc.description.abstractAngiotensin II type 1 receptor (AT1R) is a prototypical class A G protein-coupled receptor (GPCR) that has an important role in cardiovascular pathologies and blood pressure regulation as well as in the central nervous system. GPCRs may exist and function as monomers, however, they can assemble to form higher order structures, and as a result of oligomerization, their function and signaling profiles can be altered. In the case of AT1R, the classical Gα<inf>q/11</inf> pathway is initiated with endogenous agonist angiotensin II binding. A variety of cardiovascular pathologies such as heart failure, diabetic nephropathy, atherosclerosis, and hypertension are associated with this pathway. Recent findings reveal that AT1R can form homodimers and activate the noncanonical (β-arrestin-mediated) pathway. Nevertheless, the exact dimerization interface and atomic details of AT1R homodimerization have not been still elucidated. Here, six different symmetrical dimer interfaces of AT1R are considered, and homodimers were constructed using other published GPCR crystal dimer interfaces as template structures. These AT1R homodimers were then inserted into the model membrane bilayers and subjected to all-atom molecular dynamics simulations. Our simulation results along with the principal component analysis and water pathway analysis suggest four different interfaces as the most plausible: symmetrical transmembrane (TM)1,2,8, TM5, TM4, and TM4,5 AT1R dimer interfaces that consist of one inactive and one active protomer. Moreover, we identified ILE2386.33 as a hub residue in the stabilization of the inactive state of AT1R. © 2024 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1021/acs.jcim.9b00294
dc.identifier.endpage4327
dc.identifier.issn1549960X
dc.identifier.issn15499596
dc.identifier.issue10
dc.identifier.pubmed31429557
dc.identifier.scopus2-s2.0-85072831833
dc.identifier.startpage4314
dc.identifier.urihttps://doi.org/10.1021/acs.jcim.9b00294
dc.identifier.urihttps://hdl.handle.net/20.500.14719/11342
dc.identifier.volume59
dc.language.isoen
dc.publisherAmerican Chemical Society
dc.relation.sourceJournal of Chemical Information and Modeling
dc.subject.authorkeywordsReceptor, Angiotensin, Type 1
dc.subject.authorkeywordsBlood Pressure
dc.subject.authorkeywordsDimerization
dc.subject.authorkeywordsDimers
dc.subject.authorkeywordsDiseases
dc.subject.authorkeywordsMolecular Dynamics
dc.subject.authorkeywordsPrincipal Component Analysis
dc.subject.authorkeywordsAngiotensin Ii
dc.subject.authorkeywordsBlood Pressure Regulation
dc.subject.authorkeywordsCentral Nervous Systems
dc.subject.authorkeywordsClass A
dc.subject.authorkeywordsDimer Interface
dc.subject.authorkeywordsDimerizations
dc.subject.authorkeywordsG Protein Coupled Receptors
dc.subject.authorkeywordsHigh-order Structure
dc.subject.authorkeywordsHigher-order Structure
dc.subject.authorkeywordsHomodimers
dc.subject.authorkeywordsPathology
dc.subject.authorkeywordsAngiotensin 1 Receptor
dc.subject.authorkeywordsChemistry
dc.subject.authorkeywordsDimerization
dc.subject.authorkeywordsHuman
dc.subject.authorkeywordsMolecular Dynamics
dc.subject.authorkeywordsMolecular Model
dc.subject.authorkeywordsPrincipal Component Analysis
dc.subject.authorkeywordsProtein Conformation
dc.subject.authorkeywordsHumans
dc.subject.authorkeywordsModels, Molecular
dc.subject.authorkeywordsMolecular Dynamics Simulation
dc.subject.authorkeywordsPrincipal Component Analysis
dc.subject.authorkeywordsProtein Conformation
dc.subject.authorkeywordsReceptor, Angiotensin, Type 1
dc.subject.indexkeywordsBlood pressure
dc.subject.indexkeywordsDimerization
dc.subject.indexkeywordsDimers
dc.subject.indexkeywordsDiseases
dc.subject.indexkeywordsMolecular dynamics
dc.subject.indexkeywordsPrincipal component analysis
dc.subject.indexkeywordsAngiotensin II
dc.subject.indexkeywordsBlood pressure regulation
dc.subject.indexkeywordsCentral nervous systems
dc.subject.indexkeywordsClass A
dc.subject.indexkeywordsDimer interface
dc.subject.indexkeywordsDimerizations
dc.subject.indexkeywordsG protein coupled receptors
dc.subject.indexkeywordsHigh-order structure
dc.subject.indexkeywordsHigher-order structure
dc.subject.indexkeywordsHomodimers
dc.subject.indexkeywordsPathology
dc.subject.indexkeywordsangiotensin 1 receptor
dc.subject.indexkeywordschemistry
dc.subject.indexkeywordsdimerization
dc.subject.indexkeywordshuman
dc.subject.indexkeywordsmolecular dynamics
dc.subject.indexkeywordsmolecular model
dc.subject.indexkeywordsprincipal component analysis
dc.subject.indexkeywordsprotein conformation
dc.subject.indexkeywordsHumans
dc.subject.indexkeywordsModels, Molecular
dc.subject.indexkeywordsMolecular Dynamics Simulation
dc.subject.indexkeywordsPrincipal Component Analysis
dc.subject.indexkeywordsProtein Conformation
dc.subject.indexkeywordsReceptor, Angiotensin, Type 1
dc.titleToward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor
dc.typeArticle
dcterms.referencesHauser, Alexander Sebastian, Trends in GPCR drug discovery: New agents, targets and indications, Nature Reviews Drug Discovery, 16, 12, pp. 829-842, (2017), Hauser, Alexander Sebastian, Pharmacogenomics of GPCR Drug Targets, Cell, 172, 1-2, pp. 41-54.e19, (2018), Whorton, Matthew R., A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein, Proceedings of the National Academy of Sciences of the United States of America, 104, 18, pp. 7682-7687, (2007), Ferré, Sergi, Oligomerization of G-protein-coupled receptors: A reality, Current Opinion in Pharmacology, 10, 1, pp. 1-5, (2010), Ferré, Sergi, G protein-coupled receptor oligomerization revisited: Functional and pharmacological perspectives, Pharmacological Reviews, 66, 2, pp. 413-434, (2014), Rasmussen, Sǒren G.F., Crystal structure of the human β2 adrenergic G-protein-coupled receptor, Nature, 450, 7168, pp. 383-387, (2007), Park, Jung-hee, Crystal structure of the ligand-free G-protein-coupled receptor opsin, Nature, 454, 7201, pp. 183-187, (2008), Wu, Beili, Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists, Science, 330, 6007, pp. 1066-1071, (2010), Manglik, Aashish, Crystal structure of the μ-opioid receptor bound to a morphinan antagonist, Nature, 485, 7398, pp. 321-326, (2012), Thompson, Aaron A., Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic, Nature, 485, 7398, pp. 395-399, (2012)
dspace.entity.typePublication
local.indexed.atScopus
person.identifier.scopus-author-id56531652600
person.identifier.scopus-author-id15135182300
person.identifier.scopus-author-id22955598300

Files